Mirum Pharmaceuticals, Inc. (MIRM) · Insider trading

What Mirum Pharmaceuticals's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months

$9.00M

1 insider, 1 trade

Sold, 12 months

$42.20M

7 insiders, 60% under a plan

Net, 12 months

−$33.20M

bought less sold

Latest filing

2026-10-06

filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

Bought Sold Largest month: $9.00M

Who traded, two years

Insider	Bought	Sold	Trades	Last trade	Holds after
Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	–	$25.15M	27	2026-09-01	216,128
Grey Michael GDirector	–	$11.10M	3	2025-12-19	0
Heron Patrick JDirector	$9.28M	–	11	2026-01-23	–
Howe JolandaSVP, GLOBAL CONTROLLER	–	$9.09M	21	2026-09-02	616
Bjerkholt EricCHIEF FINANCIAL OFFICER	–	$4.29M	14	2026-09-14	44,745
Radovich PeterPRESIDENT AND COO	–	$3.71M	10	2026-03-16	40,272
Ramasastry SairaDirector	–	$2.30M	12	2026-06-01	0
Quan JoanneCHIEF MEDICAL OFFICER	–	$1.78M	4	2026-03-16	18,864
Brege LauraDirector	–	$1.26M	2	2025-09-11	17,194
Fairey WilliamDirector	–	$155,089	1	2025-06-11	2,500

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

Date	Insider	Trade	Shares	Price	Value	Holds after	Filing
2026-09-14	Bjerkholt EricCHIEF FINANCIAL OFFICER	Sale	9,943	98.37	$978,093	44,745	Form 4
2026-09-02	Howe JolandaSVP, GLOBAL CONTROLLER	Saleplan	658	100.00	$65,800	616	Form 4
2026-09-01	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Saleplan	8,312	98.08	$815,241	216,128	Form 4
2026-09-01	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Saleplan	21,688	98.91	$2.15M	194,440	Form 4
2026-08-18	Howe JolandaSVP, GLOBAL CONTROLLER	Sale	40,000	100.00	$4.00M	1,274	Form 4
2026-08-11	Bjerkholt EricCHIEF FINANCIAL OFFICER	Saleplan	6,001	99.90	$599,500	36,355	Form 4
2026-08-10	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Saleplan	11,683	98.51	$1.15M	202,626	Form 4
2026-08-10	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Saleplan	6,017	99.25	$597,187	196,609	Form 4
2026-08-10	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Saleplan	2,300	100.14	$230,322	194,309	Form 4
2026-08-03	Howe JolandaSVP, GLOBAL CONTROLLER	Saleplan	1,840	105.29	$193,734	1,274	Form 4
2026-07-06	Bjerkholt EricCHIEF FINANCIAL OFFICER	Saleplan	3,124	121.67	$380,097	44,057	Form 4
2026-07-06	Bjerkholt EricCHIEF FINANCIAL OFFICER	Saleplan	1,048	122.43	$128,307	43,009	Form 4
2026-07-06	Bjerkholt EricCHIEF FINANCIAL OFFICER	Saleplan	528	123.84	$65,388	42,481	Form 4
2026-07-06	Bjerkholt EricCHIEF FINANCIAL OFFICER	Saleplan	300	124.94	$37,482	42,181	Form 4
2026-07-06	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Saleplan	12,134	121.65	$1.48M	202,175	Form 4
2026-07-06	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Saleplan	4,181	122.34	$511,504	197,994	Form 4
2026-07-06	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Saleplan	1,975	123.74	$244,386	196,019	Form 4
2026-07-06	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Saleplan	1,710	124.79	$213,391	194,309	Form 4
2026-07-01	Howe JolandaSVP, GLOBAL CONTROLLER	Saleplan	2,721	120.00	$326,520	3,114	Form 4
2026-06-17	Howe JolandaSVP, GLOBAL CONTROLLER	Saleplan	2,594	101.95	$264,458	5,835	Form 4
2026-06-08	Bjerkholt EricCHIEF FINANCIAL OFFICER	Saleplan	2,258	92.84	$209,633	47,530	Form 4
2026-06-08	Bjerkholt EricCHIEF FINANCIAL OFFICER	Saleplan	1,175	93.95	$110,391	46,355	Form 4
2026-06-08	Bjerkholt EricCHIEF FINANCIAL OFFICER	Saleplan	1,567	95.12	$149,053	44,788	Form 4
2026-06-01	Ramasastry SairaDirector	Sale	3,977	100.00	$397,700	0	Form 4
2026-06-01	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Saleplan	2,602	94.64	$246,253	221,707	Form 4
2026-06-01	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Saleplan	16,595	95.34	$1.58M	205,112	Form 4
2026-06-01	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Saleplan	6,926	96.15	$665,935	198,186	Form 4
2026-06-01	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Saleplan	1,973	97.56	$192,486	196,213	Form 4
2026-06-01	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Saleplan	1,021	98.20	$100,262	195,192	Form 4
2026-06-01	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Saleplan	883	99.66	$88,000	194,309	Form 4
2026-05-15	Ramasastry SairaDirector	Saleplan	2,000	109.47	$218,940	0	Form 4
2026-04-15	Ramasastry SairaDirector	Saleplan	2,000	96.90	$193,800	0	Form 4
2026-03-16	Bjerkholt EricCHIEF FINANCIAL OFFICER	Sale	7,287	91.98	$670,258	49,788	Form 4
2026-03-16	Ramasastry SairaDirector	Saleplan	2,000	90.76	$181,520	0	Form 4
2026-03-16	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Sale	40,985	91.98	$3.77M	194,309	Form 4
2026-03-16	Radovich PeterPRESIDENT AND COO	Sale	16,515	91.98	$1.52M	40,272	Form 4
2026-03-16	Quan JoanneCHIEF MEDICAL OFFICER	Sale	7,287	91.98	$670,258	18,864	Form 4
2026-03-16	Howe JolandaSVP, GLOBAL CONTROLLER	Sale	4,732	91.98	$435,249	8,429	Form 4
2026-02-13	Ramasastry SairaDirector	Saleplan	2,000	102.09	$204,180	0	Form 4
2026-02-02	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Sale	9,108	103.30	$940,856	160,294	Form 4

65 more

2026-02-02	Radovich PeterPRESIDENT AND COO	Sale	2,631	103.30	$271,782	20,655	Form 4
2026-02-02	Howe JolandaSVP, GLOBAL CONTROLLER	Sale	968	103.30	$99,994	4,503	Form 4
2026-01-26	Bjerkholt EricCHIEF FINANCIAL OFFICER	Sale	1,053	96.19	$101,288	43,741	Form 4
2026-01-26	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Sale	6,831	96.19	$657,074	169,402	Form 4
2026-01-26	Radovich PeterPRESIDENT AND COO	Sale	3,143	96.19	$302,325	23,286	Form 4
2026-01-26	Howe JolandaSVP, GLOBAL CONTROLLER	Sale	842	96.19	$80,992	3,700	Form 4
2026-01-23	Heron Patrick JDirector	Buyindirect	131,425	68.48	$9.00M	459,010	Form 4
2026-01-22	Bjerkholt EricCHIEF FINANCIAL OFFICER	Sale	1,421	93.33	$132,622	42,127	Form 4
2026-01-22	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Sale	7,098	93.33	$662,456	163,733	Form 4
2026-01-22	Radovich PeterPRESIDENT AND COO	Sale	2,382	93.33	$222,312	20,679	Form 4
2026-01-22	Quan JoanneCHIEF MEDICAL OFFICER	Sale	1,822	93.33	$170,047	12,817	Form 4
2026-01-22	Howe JolandaSVP, GLOBAL CONTROLLER	Sale	926	93.33	$86,424	3,042	Form 4
2026-01-20	Quan JoanneCHIEF MEDICAL OFFICER	Sale	6,911	90.27	$623,856	11,305	Form 4
2026-01-15	Ramasastry SairaDirector	Saleplan	2,000	90.99	$181,980	0	Form 4
2025-12-22	Ramasastry SairaDirector	Saleplan	5,000	80.00	$400,000	0	Form 4
2025-12-19	Grey Michael GDirector	Saleplan	50,000	78.00	$3.90M	0	Form 4
2025-12-18	Ramasastry SairaDirector	Saleplan	1,000	69.46	$69,460	1,000	Form 4
2025-12-18	Ramasastry SairaDirector	Saleplan	1,000	70.00	$70,000	0	Form 4
2025-12-01	Grey Michael GDirector	Saleplan	50,000	74.00	$3.70M	0	Form 4
2025-11-21	Grey Michael GDirector	Saleplan	50,000	70.00	$3.50M	0	Form 4
2025-09-12	Bjerkholt EricCHIEF FINANCIAL OFFICER	Sale	9,578	76.01	$728,024	39,945	Form 4
2025-09-11	Brege LauraDirector	Sale	15,509	74.34	$1.15M	17,194	Form 4
2025-09-11	Brege LauraDirector	Sale	1,491	75.07	$111,929	15,703	Form 4
2025-09-08	Ramasastry SairaDirector	Sale	17,000	–	–	0	Form 4
2025-08-11	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Saleplan	40,000	62.00	$2.48M	138,641	Form 4
2025-08-11	Bjerkholt EricCHIEF FINANCIAL OFFICER	Sale	8,000	–	–	28,236	Form 4
2025-08-07	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Saleplan	40,000	55.25	$2.21M	138,641	Form 4
2025-08-07	Howe JolandaSVP, GLOBAL CONTROLLER	Saleplan	10,000	58.00	$580,000	2,426	Form 4
2025-07-03	Howe JolandaSVP, GLOBAL CONTROLLER	Saleplan	477	49.08	$23,411	2,426	Form 4
2025-07-02	Howe JolandaSVP, GLOBAL CONTROLLER	Saleplan	564	48.25	$27,213	2,903	Form 4
2025-06-11	Fairey WilliamDirector	Sale	3,203	48.42	$155,089	2,500	Form 4
2025-06-03	Ramasastry SairaDirector	Sale	2,500	45.74	$114,350	0	Form 4
2025-06-02	Ramasastry SairaDirector	Sale	5,703	46.20	$263,479	0	Form 4
2025-03-18	Howe JolandaSVP, GLOBAL CONTROLLER	Saleplan	2,415	44.45	$107,347	2,426	Form 4
2025-03-17	Heron Patrick JDirector	Buyindirect	21	43.93	$923	168,672	Form 4
2025-03-17	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Sale	27,279	44.21	$1.21M	138,641	Form 4
2025-03-17	Radovich PeterPRESIDENT AND COO	Sale	7,879	44.21	$348,331	18,672	Form 4
2025-03-17	Howe JolandaSVP, GLOBAL CONTROLLER	Saleplan	2,900	44.21	$128,209	6,647	Form 4
2025-03-17	Howe JolandaSVP, GLOBAL CONTROLLER	Saleplan	50,111	44.33	$2.22M	9,436	Form 4
2025-03-17	Howe JolandaSVP, GLOBAL CONTROLLER	Saleplan	2,789	44.75	$124,808	6,647	Form 4
2025-03-17	Howe JolandaSVP, GLOBAL CONTROLLER	Saleplan	1,806	44.36	$80,114	4,841	Form 4
2025-03-14	Heron Patrick JDirector	Buyindirect	528	44.11	$23,290	168,651	Form 4
2025-03-11	Heron Patrick JDirector	Buyindirect	963	43.77	$42,151	168,123	Form 4
2025-03-10	Heron Patrick JDirector	Buyindirect	758	42.66	$32,336	166,583	Form 4
2025-03-10	Heron Patrick JDirector	Buyindirect	577	43.37	$25,024	167,160	Form 4
2025-03-07	Heron Patrick JDirector	Buyindirect	580	43.21	$25,062	165,825	Form 4
2025-03-06	Heron Patrick JDirector	Buyindirect	1,335	43.89	$58,593	165,245	Form 4
2025-03-05	Heron Patrick JDirector	Buyindirect	267	44.55	$11,895	163,910	Form 4
2025-03-04	Heron Patrick JDirector	Buyindirect	1,279	45.55	$58,258	163,587	Form 4
2025-03-04	Heron Patrick JDirector	Buyindirect	56	45.96	$2,574	163,643	Form 4
2025-03-04	Radovich PeterPRESIDENT AND COO	Sale	13,681	45.57	$623,443	13,280	Form 4
2025-03-04	Radovich PeterPRESIDENT AND COO	Sale	1,169	45.74	$53,470	12,111	Form 4
2025-03-03	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Saleplan	19,392	46.61	$903,861	136,528	Form 4
2025-03-03	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Saleplan	20,608	47.19	$972,492	115,920	Form 4
2025-02-03	Howe JolandaSVP, GLOBAL CONTROLLER	Sale	1,064	48.22	$51,306	4,232	Form 4
2025-02-03	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Sale	9,102	48.22	$438,898	115,920	Form 4
2025-02-03	Radovich PeterPRESIDENT AND COO	Sale	2,627	48.22	$126,674	26,961	Form 4
2025-01-24	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Sale	6,837	47.92	$327,629	125,022	Form 4
2025-01-24	Howe JolandaSVP, GLOBAL CONTROLLER	Sale	902	47.92	$43,224	3,524	Form 4
2025-01-24	Radovich PeterPRESIDENT AND COO	Sale	3,177	47.92	$152,242	29,588	Form 4
2025-01-17	Quan JoanneCHIEF MEDICAL OFFICER	Sale	6,969	45.86	$319,598	5,649	Form 4
2025-01-07	Howe JolandaSVP, GLOBAL CONTROLLER	Sale	750	42.82	$32,115	2,926	Form 4
2025-01-07	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Sale	7,489	42.82	$320,679	119,359	Form 4
2025-01-07	Radovich PeterPRESIDENT AND COO	Sale	1,998	42.82	$85,554	27,015	Form 4
2024-11-14	Howe JolandaSVP, GLOBAL CONTROLLER	Sale	2,500	47.10	$117,750	2,426	Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

73 × option exercise3 × grant or award1 × other1 × gift

Show them

Date	Insider	What	Shares	Price	Holds after	Filing
2026-10-06	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Option exercise M	+5,305	19.19	199,745	Form 4
2026-10-06	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Option exercise M	+6,892	15.87	206,637	Form 4
2026-09-11	Bjerkholt EricCHIEF FINANCIAL OFFICER	Option exercise M	+18,333	–	54,688	Form 4
2026-09-01	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Option exercise M	+30,000	2.94	224,440	Form 4
2026-08-18	Howe JolandaSVP, GLOBAL CONTROLLER	Option exercise M	+40,000	6.27	41,274	Form 4
2026-08-10	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Option exercise M	+20,000	2.94	214,309	Form 4
2026-07-06	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Option exercise M	+20,000	2.94	214,309	Form 4
2026-06-09	Bjerkholt EricCHIEF FINANCIAL OFFICER	Option exercise M	+2,393	26.49	47,181	Form 4
2026-06-05	Radovich PeterPRESIDENT AND COO	Option exercise M	+16,988	19.19	57,260	Form 4
2026-06-01	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Option exercise M	+30,000	2.94	224,309	Form 4
2026-05-29	Walbert Timothy PDirector	Option exercise M	+3,977	–	9,680	Form 4
2026-05-29	Fischer LaurentDirector	Option exercise M	+3,977	–	10,727	Form 4
2026-05-29	Ramasastry SairaDirector	Option exercise M	+3,977	–	3,977	Form 4
2026-05-29	Cardon LonDirector	Option exercise M	+3,977	–	9,680	Form 4
2026-05-15	Ramasastry SairaDirector	Option exercise M	+2,000	23.51	2,000	Form 4
2026-04-15	Ramasastry SairaDirector	Option exercise M	+2,000	23.51	2,000	Form 4
2026-03-16	Ramasastry SairaDirector	Option exercise M	+2,000	23.51	2,000	Form 4
2026-03-15	Bjerkholt EricCHIEF FINANCIAL OFFICER	Option exercise M	+13,334	–	57,075	Form 4
2026-03-15	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Option exercise M	+25,000	–	185,294	Form 4
2026-03-15	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Option exercise M	+50,000	–	235,294	Form 4
2026-03-15	Radovich PeterPRESIDENT AND COO	Option exercise M	+7,220	–	33,787	Form 4
2026-03-15	Radovich PeterPRESIDENT AND COO	Option exercise M	+23,000	–	56,787	Form 4
2026-03-15	Quan JoanneCHIEF MEDICAL OFFICER	Option exercise M	+13,334	–	26,151	Form 4
2026-03-15	Howe JolandaSVP, GLOBAL CONTROLLER	Option exercise M	+2,658	–	7,161	Form 4
2026-03-15	Howe JolandaSVP, GLOBAL CONTROLLER	Option exercise M	+6,000	–	13,161	Form 4
2026-03-06	Radovich PeterPRESIDENT AND COO	Option exercise M	+5,912	15.87	26,567	Form 4
2026-02-13	Ramasastry SairaDirector	Option exercise M	+2,000	23.51	2,000	Form 4
2026-01-31	Howe JolandaSVP, GLOBAL CONTROLLER	Option exercise M	+1,771	–	5,471	Form 4
2026-01-23	Bjerkholt EricCHIEF FINANCIAL OFFICER	Option exercise M	+2,667	–	44,794	Form 4
2026-01-23	Heron Patrick JDirector	Other J	+159,277	–	327,585	Form 4
2026-01-23	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Option exercise M	+12,500	–	176,233	Form 4
2026-01-23	Radovich PeterPRESIDENT AND COO	Option exercise M	+5,750	–	26,429	Form 4
2026-01-23	Howe JolandaSVP, GLOBAL CONTROLLER	Option exercise M	+1,500	–	4,542	Form 4
2026-01-21	Bjerkholt EricCHIEF FINANCIAL OFFICER	Option exercise M	+3,334	–	43,548	Form 4
2026-01-21	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Option exercise M	+12,797	–	170,831	Form 4
2026-01-21	Radovich PeterPRESIDENT AND COO	Option exercise M	+4,167	–	23,061	Form 4
2026-01-21	Quan JoanneCHIEF MEDICAL OFFICER	Option exercise M	+3,334	–	14,639	Form 4
2026-01-21	Howe JolandaSVP, GLOBAL CONTROLLER	Option exercise M	+1,542	–	3,968	Form 4
2026-01-16	Quan JoanneCHIEF MEDICAL OFFICER	Option exercise M	+12,500	–	18,216	Form 4
2026-01-15	Ramasastry SairaDirector	Option exercise M	+2,000	23.51	2,000	Form 4
2025-12-31	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Gift G	−21,070	–	187,500	Form 4
2025-12-22	Ramasastry SairaDirector	Option exercise M	+5,000	23.51	5,000	Form 4
2025-12-19	Grey Michael GDirector	Option exercise M	+50,000	2.94	50,000	Form 4
2025-12-18	Ramasastry SairaDirector	Option exercise M	+2,000	23.51	2,000	Form 4
2025-12-01	Grey Michael GDirector	Option exercise M	+50,000	2.94	50,000	Form 4
2025-11-21	Grey Michael GDirector	Option exercise M	+50,000	2.94	50,000	Form 4
2025-11-18	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Option exercise M	+19,133	19.24	158,034	Form 4
2025-09-11	Bjerkholt EricCHIEF FINANCIAL OFFICER	Option exercise M	+18,333	–	49,523	Form 4
2025-09-11	Brege LauraDirector	Option exercise M	+17,000	15.00	32,703	Form 4
2025-09-08	Ramasastry SairaDirector	Option exercise M	+17,000	23.51	17,000	Form 4
2025-08-12	Bjerkholt EricCHIEF FINANCIAL OFFICER	Option exercise M	+2,954	26.49	31,190	Form 4
2025-08-11	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Option exercise M	+40,000	2.94	178,641	Form 4
2025-08-07	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Option exercise M	+40,000	2.94	178,641	Form 4
2025-08-07	Howe JolandaSVP, GLOBAL CONTROLLER	Option exercise M	+10,000	6.27	12,426	Form 4
2025-07-01	Howe JolandaSVP, GLOBAL CONTROLLER	Option exercise M	+1,041	–	3,467	Form 4
2025-06-03	Ramasastry SairaDirector	Option exercise M	+2,500	14.12	2,500	Form 4
2025-05-29	Walbert Timothy PDirector	Option exercise M	+5,703	–	5,703	Form 4
2025-05-29	Cardon LonDirector	Option exercise M	+5,703	–	5,703	Form 4
2025-05-29	Fairey WilliamDirector	Option exercise M	+5,703	–	5,703	Form 4
2025-05-29	Brege LauraDirector	Option exercise M	+5,703	–	15,703	Form 4
2025-05-29	Heron Patrick JDirector	Option exercise M	+5,703	–	5,703	Form 4
2025-05-29	Ramasastry SairaDirector	Option exercise M	+5,703	–	5,703	Form 4
2025-03-17	Howe JolandaSVP, GLOBAL CONTROLLER	Option exercise M	+52,900	2.94	59,547	Form 4
2025-03-15	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Option exercise M	+50,000	–	165,920	Form 4
2025-03-15	Radovich PeterPRESIDENT AND COO	Option exercise M	+14,440	–	26,551	Form 4
2025-03-15	Howe JolandaSVP, GLOBAL CONTROLLER	Option exercise M	+5,315	–	9,547	Form 4
2025-03-03	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Option exercise M	+40,000	2.94	155,920	Form 4
2025-01-31	Howe JolandaSVP, GLOBAL CONTROLLER	Option exercise M	+1,772	–	5,296	Form 4
2025-01-23	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Option exercise M	+12,500	–	131,859	Form 4
2025-01-23	Howe JolandaSVP, GLOBAL CONTROLLER	Option exercise M	+1,500	–	4,426	Form 4
2025-01-23	Bjerkholt EricCHIEF FINANCIAL OFFICER	Option exercise M	+2,667	–	35,946	Form 4
2025-01-23	Radovich PeterPRESIDENT AND COO	Option exercise M	+5,750	–	32,765	Form 4
2025-01-16	Quan JoanneCHIEF MEDICAL OFFICER	Option exercise M	+12,500	–	12,618	Form 4
2025-01-06	Howe JolandaSVP, GLOBAL CONTROLLER	Option exercise M	+1,250	–	3,676	Form 4
2024-11-14	Howe JolandaSVP, GLOBAL CONTROLLER	Option exercise M	+2,500	2.94	4,926	Form 4
2024-11-08	Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER	Grant or award A	+65	21.05	126,848	Form 4
2024-11-08	Bjerkholt EricCHIEF FINANCIAL OFFICER	Grant or award A	+475	21.05	33,279	Form 4
2024-11-08	Quan JoanneCHIEF MEDICAL OFFICER	Grant or award A	+118	21.05	118	Form 4

How to read it

Buy, sale: Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan: A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after: The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value: Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

Mirum Pharmaceuticals's scores and multiples ›